Haseeb R Jabbar1, Ali Abbas2, Mustafa Ahmed3, Charles T Klodell4, Myron Chang5, Yunfeng Dai5, Peter V Draganov6. 1. Department of Internal Medicine, University of Florida College of Medicine, 1600 SW Archer Road, Gainesville, FL, 32610-3003, USA. Haseeb.Jabbar@medicine.ufl.edu. 2. Department of Internal Medicine, University of Florida College of Medicine, 1600 SW Archer Road, Gainesville, FL, 32610-3003, USA. 3. Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA. 4. Division of Thoracic and Cardiovascular Surgery, University of Florida, Gainesville, FL, USA. 5. Department of Biostatistics, University of Florida, Gainesville, FL, USA. 6. Division of Gastroenterology and Hepatology, University of Florida, Gainesville, FL, USA.
Abstract
OBJECTIVES: To evaluate rate, recurrence, and predictors of gastrointestinal bleeding (GIB) and impact of endoscopy in left ventricular assist device (LVAD) patients. METHODS: This is a cohort study of all patients who received the current-generation continuous-flow HeartMate II LVAD from 2005 to 2013 at our institution. Patients were followed up, and GIB events recorded until death, time of heart transplantation, or end of observation. RESULTS: LVAD was implanted in 112 patients (median age 67 years, 88% male). A total of 44 patients (39%) had 74 GIB events occurring at a rate of 42.9 per 100 p-y. Endoscopy was performed in 77% of patients, and GIB source was identified in 57% with upper GIB found in almost two-third of cases. Right ventricular dysfunction and post-LVAD ejection fraction >30% were associated with higher GIB rates. Higher pulsatility index was associated with lower GIB rates. Re-bleeding occurred in 19 (43%) patients at a rate of 62.5 per 100 p-y and was not affected by endoscopic therapy at the index endoscopy. CONCLUSIONS: GIB in LVAD patients is common, occurring primarily in the upper GI tract. Upper endoscopy is the preferred strategy though lower endoscopy is also recommended for a full workup. Endoscopy can identify GIB lesions in about 50% of patients, but re-bleeding is common. Right ventricular dysfunction and post-LVAD ejection fraction >30% are associated with higher GIB rates. Higher pulsatility index is associated with lower GIB rates. Reduction in pump speed is a potential strategy for managing and preventing GIB.
OBJECTIVES: To evaluate rate, recurrence, and predictors of gastrointestinal bleeding (GIB) and impact of endoscopy in left ventricular assist device (LVAD) patients. METHODS: This is a cohort study of all patients who received the current-generation continuous-flow HeartMate II LVAD from 2005 to 2013 at our institution. Patients were followed up, and GIB events recorded until death, time of heart transplantation, or end of observation. RESULTS:LVAD was implanted in 112 patients (median age 67 years, 88% male). A total of 44 patients (39%) had 74 GIB events occurring at a rate of 42.9 per 100 p-y. Endoscopy was performed in 77% of patients, and GIB source was identified in 57% with upper GIB found in almost two-third of cases. Right ventricular dysfunction and post-LVAD ejection fraction >30% were associated with higher GIB rates. Higher pulsatility index was associated with lower GIB rates. Re-bleeding occurred in 19 (43%) patients at a rate of 62.5 per 100 p-y and was not affected by endoscopic therapy at the index endoscopy. CONCLUSIONS: GIB in LVADpatients is common, occurring primarily in the upper GI tract. Upper endoscopy is the preferred strategy though lower endoscopy is also recommended for a full workup. Endoscopy can identify GIB lesions in about 50% of patients, but re-bleeding is common. Right ventricular dysfunction and post-LVAD ejection fraction >30% are associated with higher GIB rates. Higher pulsatility index is associated with lower GIB rates. Reduction in pump speed is a potential strategy for managing and preventing GIB.
Authors: George V Letsou; Nyma Shah; Igor D Gregoric; Timothy J Myers; Reynolds Delgado; O H Frazier Journal: J Heart Lung Transplant Date: 2005-01 Impact factor: 10.247
Authors: Jolanta Klovaite; Finn Gustafsson; Svend A Mortensen; Kåre Sander; Lars B Nielsen Journal: J Am Coll Cardiol Date: 2009-06-09 Impact factor: 24.094
Authors: Omar Wever-Pinzon; Craig H Selzman; Stavros G Drakos; Abdulfattah Saidi; Gregory J Stoddard; Edward M Gilbert; Mohamed Labedi; Bruce B Reid; Erin S Davis; Abdallah G Kfoury; Dean Y Li; Josef Stehlik; Feras Bader Journal: Circ Heart Fail Date: 2013-03-11 Impact factor: 8.790
Authors: Marc D Samsky; Chetan B Patel; Tracy A DeWald; Alastair D Smith; G Michael Felker; Joseph G Rogers; Adrian F Hernandez Journal: J Am Coll Cardiol Date: 2013-04-17 Impact factor: 24.094
Authors: Khawaja A Ammar; Matt M Umland; Christopher Kramer; Nasir Sulemanjee; M Fuad Jan; Bijoy K Khandheria; James B Seward; Timothy E Paterick Journal: Eur Heart J Cardiovasc Imaging Date: 2012-05-10 Impact factor: 6.875
Authors: Anthony E Peters; LaVone A Smith; Priscilla Ababio; Khadijah Breathett; Timothy L McMurry; Jamie L W Kennedy; Mohammad Abuannadi; James Bergin; Sula Mazimba Journal: J Card Fail Date: 2019-02-18 Impact factor: 5.712